Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,511 | -10,087 | -113,575 | -82,880 | -68,679 |
| Depreciation Amortization | 4,235 | 2,135 | 7,384 | 5,279 | 3,224 |
| Accounts receivable | -4,573 | -60,211 | -11,103 | -10,080 | -11,673 |
| Accounts payable and accrued liabilities | -5,613 | 8,194 | -7,008 | -11,388 | -5,506 |
| Other Working Capital | 29,714 | -26,317 | -5,142 | -22,183 | -6,260 |
| Other Operating Activity | 51,865 | 70,156 | 105,339 | 90,100 | 65,004 |
| Operating Cash Flow | $28,117 | $-16,130 | $-24,105 | $-31,152 | $-23,890 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -609 | -550 | -245 |
| Purchase Of Investment | -127,974 | -86,715 | -107,502 | -71,112 | -38,600 |
| Sale Of Investment | 94,597 | 42,132 | 50,488 | 11,457 | 0 |
| Investing Cash Flow | $-33,377 | $-44,583 | $-57,623 | $-60,205 | $-38,845 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | N/A | 105,000 | 75,000 | 75,000 |
| Debt Repayment | -80,000 | N/A | N/A | 0 | N/A |
| Common Stock Issued | 1,276 | 1,082 | 7,652 | 7,151 | 6,141 |
| Other Financing Activity | -13,418 | 0 | -4,201 | -4,192 | -4,192 |
| Financing Cash Flow | $-67,142 | $1,082 | $108,451 | $77,959 | $76,949 |
| Beginning Cash Position | 112,738 | 112,738 | 86,015 | 86,015 | 86,015 |
| End Cash Position | 40,336 | 53,107 | 112,738 | 72,617 | 100,229 |
| Net Cash Flow | $-72,402 | $-59,631 | $26,723 | $-13,398 | $14,214 |
| Free Cash Flow | |||||
| Operating Cash Flow | 28,117 | -16,130 | -24,105 | -31,152 | -23,890 |
| Capital Expenditure | N/A | N/A | -609 | -550 | -245 |
| Free Cash Flow | 28,117 | -16,130 | -24,714 | -31,702 | -24,135 |